Luye Pharma Announces USD150 Million Exchangeable Shares Issuance
TipRanks Black Friday Sale
An announcement from Luye Pharma Group ( (HK:2186) ) is now available.
Luye Pharma Group announced the issuance of exchangeable preference shares by its wholly-owned subsidiary, which involves a subscription agreement with a third-party subscriber for USD150 million. This transaction will result in a reduction of Luye Pharma’s shareholding in Boan Biotech, potentially affecting its control over the subsidiary and constituting a discloseable transaction under Hong Kong’s listing rules.
The most recent analyst rating on (HK:2186) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on Luye Pharma Group stock, see the HK:2186 Stock Forecast page.
More about Luye Pharma Group
Luye Pharma Group Ltd. is a pharmaceutical company incorporated in Bermuda, focusing on the development, production, and sale of innovative pharmaceutical products. The company operates in the healthcare industry, providing a range of therapeutic solutions and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 43,144,349
Technical Sentiment Signal: Hold
Current Market Cap: HK$12.06B
See more data about 2186 stock on TipRanks’ Stock Analysis page.
